Dubroff: Time for Trump to release tax returns, explain Russian ties
Two of the smartest journalists I know are Thomas J. Friedman of the New York Times and Fareed Zakaria of CNN. When they reach the same conclusion about Donald Trump, the Russians and his tax returns, I’m pretty confident they’re on to something. That’s why I’ll add this newspaper’s voice to those calling for President Read More →
The Trade Desk reports strong income growth
The Trade Desk reported a 29 percent increase in net income in its fiscal year 2016 earnings statement Feb. 16 and filed a proposal with the Securities and Exchange Commission for a follow-on stock offering. The Ventura advertising platform company made $10.3 million in the fourth quarter of 2016 for a total of $20.5 million Read More →
AeroVironment releases pilot program details at expo
Unmanned aircraft systems company AeroVironment published details from its pilot program and debuted a new drone and support system at the World Ag Expo and National Farm Machinery Show Feb. 14 in Tulare, CA. Based in Monrovia, with operations in Simi Valley, the company partnered with farmers and universities to develop a drone that would Read More →
Our view: Puzder ground into political hamburger
Just a day before his confirmation hearing, CKE Restaurants and subsidiaries Carl’s Jr. and Hardee’s CEO Andy Puzder has withdrawn his nomination for secretary of labor. Puzder, a former Santa Barbara resident who was ideologically in step with President Donald Trump, was rapidly losing support from the left as well as the right. And after Read More →
Amgen applies for FDA approval of Blincyto
Thousand Oaks-based Amgen submitted an application for Blincyto to the U.S. Food and Drug Administration, the company announced on Feb. 14. Amgen aims to gain approval for Blincyto to treat Philadelphia chromosome-positive relapsed or refractory B-cell precursor acute lymphoblastic leukemia. The drug was previously granted breakthrough therapy designation and accelerated approval in December 2014. “Acute Read More →